Response to Cabozantinib Following Acquired Entrectinib Resistance in a Patient With ETV6-NTRK3 Fusion-Positive Carcinoma Harboring the NTRK3G623R Solvent-Front Mutation

Research output: Contribution to journal › Case report › Contributed › peer-review

Contributors

Dorothea Hanf - (Author)
Christoph Heining - , National Center for Tumor Diseases (Partners: UKD, MFD, HZDR, DKFZ) (Author)
Karin Laaber - (Author)
Heiner Nebelung - , Institute and Polyclinic of Diagnostic and Interventional Radiology (Author)
Sebastian Uhrig - (Author)
Barbara Hutter - (Author)
Arne Jahn - , Institute of Clinical Genetics (Author)
Daniela Richter - (Author)
Daniela Aust - , Institute of Pathology (Author)
Friederike Herbst - (Author)
Stefan Fröhling - (Author)
Hanno Glimm - , Department of internal Medicine I, National Center for Tumor Diseases (Partners: UKD, MFD, HZDR, DKFZ) (Author)
Gunnar Folprecht - , Department of internal Medicine I, University Cancer Centre (Author)

Scopus	85117736711